We are live on ! Find out more
HQL

abrdn Life Sciences Investors
HQL

79 hedge funds and large institutions have $126M invested in abrdn Life Sciences Investors in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 23

11% more capital invested

Capital invested by funds: $113M → $126M (+$13M)

3.25% more ownership

Funds ownership: 32% → 35.25% (+3.3%)

0% more funds holding

Funds holding: 79 → 79 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 13

Holders
79
Holders Change
–
Holders Change %
0%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
30
Reduced
23
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
+$14.4M
2
AIA
Absolute Investment Advisers
Florida
+$8.28M
3
KIM
Karpus Investment Management
New York
+$4.78M
4
QL
Quarry LP
New York
+$2.13M
5
CA
Cetera Advisors
Colorado
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
CA
Cornerstone Advisors
North Carolina
-$6.4M
2
Morgan Stanley
Morgan Stanley
New York
-$5.21M
3
CCP
Clough Capital Partners
Massachusetts
-$3.54M
4
WAM
Wolverine Asset Management
Illinois
-$2.66M
5
LSC
Logan Stone Capital
Illinois
-$1.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$1.03M +$36.1K +2,612 +4%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$590K -$17K -1,230 -3%
UBS Group
28
UBS Group
Switzerland
$577K +$74.2K +5,363 +15%
Qube Research & Technologies (QRT)
29
Qube Research & Technologies (QRT)
United Kingdom
$522K +$11.7K +847 +2%
KWM
30
Kingsview Wealth Management
Oregon
$490K -$13.3K -963 -3%
MC
31
Matisse Capital
Oregon
$468K +$337K +24,333 +243%
Commonwealth Equity Services
32
Commonwealth Equity Services
Massachusetts
$449K -$1.2K -87 -0.3%
CA
33
Cornerstone Advisors
North Carolina
$435K -$6.4M -462,426 -94%
PAG
34
Private Advisor Group
New Jersey
$433K -$33.4K -2,411 -7%
BBPWM
35
Blue Bell Private Wealth Management
Pennsylvania
$429K +$296K +21,369 +211%
AUB
36
Atlantic Union Bankshares
Virginia
$427K -$51K -3,687 -11%
RJA
37
Raymond James & Associates
Florida
$406K +$47.5K +3,433 +13%
GC
38
Guggenheim Capital
Illinois
$349K -$49.3K -3,564 -12%
NA
39
NewEdge Advisors
Louisiana
$340K +$34.1K +2,463 +11%
Stifel Financial
40
Stifel Financial
Missouri
$330K -$57.1K -4,125 -15%
KAS
41
KPP Advisory Services
Kentucky
$326K +$331K +23,932 New
Two Sigma Investments
42
Two Sigma Investments
New York
$321K +$326K +23,540 New
Invesco
43
Invesco
Georgia
$287K +$291K +21,044 New
Wealth Enhancement Advisory Services
44
Wealth Enhancement Advisory Services
Minnesota
$279K +$13.7K +991 +5%
OC
45
Oppenheimer & Co
New York
$251K +$11.3K +814 +5%
Millennium Management
46
Millennium Management
New York
$248K -$221K -15,951 -47%
Cerity Partners
47
Cerity Partners
New York
$213K – – –
WS
48
Wedbush Securities
California
$210K -$65K -4,700 -23%
WAM
49
Wolverine Asset Management
Illinois
$203K -$2.66M -192,463 -93%
LSC
50
Logan Stone Capital
Illinois
$201K -$1.88M -136,236 -90%
1
2
3 4

HQL Hedge Fund Activity: Q1 2024 in Review

79 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2024, worth a combined $126M — up 11% from $113M a quarter earlier.

Fund positioning in HQL was balanced in Q1 2024: 13 funds opened new positions, 13 closed out, 30 added to existing stakes and 23 trimmed.

The largest buyer was Saba Capital Management, adding an estimated $14.4M. The largest seller was Cornerstone Advisors, cutting an estimated $6.4M.

  • 79 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $126M of abrdn Life Sciences Investors stock for Q1 2024, up 11% quarter-over-quarter.
  • 13 funds opened new abrdn Life Sciences Investors positions in Q1 2024 and 13 closed out, a net change of 0 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2024 was Saba Capital Management, an estimated $14.4M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2024 was Cornerstone Advisors, an estimated $6.4M sold.

Based on aggregated 13F filings for Q1 2024.